Envoy Medical (COCH) Net Margin (2022 - 2026)
Envoy Medical (COCH) reported Net Margin of 14617.95% for Q1 2026, down 106143.0% on a YoY basis from N/an in Q1 2025, and down 41.7% sequentially from 10316.0% in Q4 2025.
Envoy Medical (COCH) Net Margin (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of Net Margin data on file, last reported at 14617.95% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 106143.0% year-over-year to 14617.95%; the trailing twelve-month figure through Mar 2026 stood at 12020.09% (up 51482.0% YoY), and the FY2025 full-year result was 11892.95%, up 53950.0% from the prior year.
- Net Margin retreated to 14617.95% in Q1 2026, from 10316.0% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1700.0% in Q3 2023 to a low of 57385.0% in Q4 2022.
- A 5-year average of 13391.85% and a median of 12881.36% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin surged 5075342 bps in 2023 and slumped 1480714 bps in 2024, its largest moves.
- Tracing COCH's Net Margin over 5 years: stood at 57385.0% in 2022, then soared by 88 bps to 6631.58% in 2023, then plunged by 176 bps to 18300.0% in 2024, then jumped by 44 bps to 10316.0% in 2025, then plunged by 42 bps to 14617.95% in 2026.
- Business Quant data shows COCH's Net Margin at 14617.95% in Q1 2026, 10316.0% in Q4 2025, and 18445.24% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -14,617.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,617.95% |
| Dec 31, 2025 | -10,316.00% |
| Sep 30, 2025 | -18,445.24% |
| Jun 30, 2025 | -8,900.00% |
| Mar 31, 2025 | -13,556.52% |
| Dec 31, 2024 | -18,300.00% |
| Sep 30, 2024 | -13,107.14% |
| Jun 30, 2024 | -7,811.76% |
| Mar 31, 2024 | -12,881.36% |
| Dec 31, 2023 | -6,631.58% |
| Sep 30, 2023 | 1,700.00% |
| Jun 30, 2023 | -1,285.10% |
| Mar 31, 2023 | -16,991.03% |
| Dec 31, 2022 | -57,385.00% |
| Sep 30, 2022 | -2,349.12% |